Search
News Chat
Login
Search
Top
For You
Business
Crypto
Culture
Environment
Politics
Science
Sports
Tech
Video Games
World
Moderna Inc News
Top stories
Moderna's mRESVIA RSV Vaccine Shows 50% Efficacy, Faces Market Scrutiny
Authors
6
8 days
Economics
Bio
Health
Articles
Latest stories
CDC Updates RSV and COVID-19 Vaccine Recommendations; Moderna RSV Efficacy and GSK Stock Fall
Authors
48
7 days
Economics
Health
Business
Moderna's mRESVIA RSV Vaccine Shows 50% Efficacy, Faces Market Scrutiny
Authors
6
8 days
Economics
Bio
Health
Moderna Inc's RSV Shot mRESVIA Shows 50% Efficacy in Preventing RSV After 18 Months
Authors
5
9 days
Bio
Health
Business
Previous
Next